6SVK
human Myeloid-derived growth factor (MYDGF)
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | SLS BEAMLINE X06DA |
Synchrotron site | SLS |
Beamline | X06DA |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2017-07-19 |
Detector | DECTRIS PILATUS 2M-F |
Wavelength(s) | 0.99999 |
Spacegroup name | P 31 2 1 |
Unit cell lengths | 48.677, 48.677, 177.846 |
Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
Resolution | 42.155 - 1.604 |
R-factor | 0.219 |
Rwork | 0.218 |
R-free | 0.24700 |
Structure solution method | SAD |
RMSD bond length | 0.010 |
RMSD bond angle | 1.070 |
Data reduction software | XDS |
Data scaling software | Aimless |
Phasing software | SHELXD |
Refinement software | BUSTER (2.11.7) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 42.155 | 1.707 |
High resolution limit [Å] | 1.604 | 1.604 |
Rmerge | 0.215 | 2.299 |
Number of reflections | 28207 | 1409 |
<I/σ(I)> | 11.9 | 1.3 |
Completeness [%] | 85.1 | 25.6 |
Redundancy | 19.1 | 15 |
CC(1/2) | 0.998 | 0.510 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 6.4 | 277.15 | 48% M1K3350 (12% w/v PEG 1000, 12% w/v PEG 3350, and 12% v/v MPD, original solution Molecular Dimensions), 1,25% NPS (3.75 mM sodium nitrate, 3.75 mM sodium phosphate dibasic, and 3.75 mM ammonium sulfate; original solution MolecularDimensions), 0.1M MMT buffer (pH 6.4) (0.02 M DL-malic acid, 0.04 M MES monohydrate, 0.04 M Tris) |